ClinicalTrials.gov record
Completed Phase 1 Interventional

Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery

ClinicalTrials.gov ID: NCT06867068

Public ClinicalTrials.gov record NCT06867068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06867068
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Albert Einstein College of Medicine
Other
Enrollment
73 participants

Conditions and interventions

Interventions

  • Fentanyl Drug
  • Ketamine Drug
  • Midazolam Hydrochloride Drug
  • Nitrous oxide Drug
  • Propofol injection Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2016
Primary completion
Jun 9, 2024
Completion
Jun 9, 2024
Last update posted
Mar 26, 2026

2016 – 2024

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
NYCHHC - Jacobi Medical Center and North Central Bronx Hospital The Bronx New York 10461

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06867068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06867068 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →